Edwards Lifesciences Corp (EW)
86.46
-1.55
(-1.76%)
USD |
NYSE |
Apr 26, 16:00
86.46
0.00 (0.00%)
After-Hours: 20:00
Edwards Lifesciences Free Cash Flow: 629.50M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | 629.50M |
| September 30, 2023 | 788.20M |
| June 30, 2023 | 682.00M |
| March 31, 2023 | 985.40M |
| December 31, 2022 | 953.40M |
| September 30, 2022 | 1.040B |
| June 30, 2022 | 1.261B |
| March 31, 2022 | 1.428B |
| December 31, 2021 | 1.402B |
| September 30, 2021 | 1.409B |
| June 30, 2021 | 1.050B |
| March 31, 2021 | 716.60M |
| December 31, 2020 | 647.00M |
| September 30, 2020 | 692.10M |
| June 30, 2020 | 940.50M |
| March 31, 2020 | 1.087B |
| December 31, 2019 | 904.50M |
| September 30, 2019 | 808.40M |
| June 30, 2019 | 704.40M |
| March 31, 2019 | 522.40M |
| December 31, 2018 | 685.00M |
| September 30, 2018 | 754.30M |
| June 30, 2018 | 772.00M |
| March 31, 2018 | 820.60M |
| December 31, 2017 | 825.20M |
| Date | Value |
|---|---|
| September 30, 2017 | 658.50M |
| June 30, 2017 | 541.20M |
| March 31, 2017 | 517.30M |
| December 31, 2016 | 487.00M |
| September 30, 2016 | 411.60M |
| June 30, 2016 | 430.50M |
| March 31, 2016 | 470.10M |
| December 31, 2015 | 443.20M |
| September 30, 2015 | 428.60M |
| June 30, 2015 | 246.20M |
| March 31, 2015 | 856.50M |
| December 31, 2014 | 928.60M |
| September 30, 2014 | 970.80M |
| June 30, 2014 | 1.086B |
| March 31, 2014 | 422.90M |
| December 31, 2013 | 362.60M |
| September 30, 2013 | 343.10M |
| June 30, 2013 | 339.10M |
| March 31, 2013 | 359.10M |
| December 31, 2012 | 246.10M |
| September 30, 2012 | 237.50M |
| June 30, 2012 | 227.80M |
| March 31, 2012 | 174.50M |
| December 31, 2011 | 223.90M |
| September 30, 2011 | 234.20M |
Free Cash Flow Range, Past 5 Years
629.50M
Minimum
Dec 2023
1.428B
Maximum
Mar 2022
954.16M
Average
940.50M
Median
Jun 2020
Free Cash Flow Benchmarks
| Stryker Corp | 3.136B |
| Boston Scientific Corp | 1.703B |
| Align Technology Inc | 608.06M |
| Abbott Laboratories | 5.059B |
| Steris PLC | 593.99M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 136.60M |
| Cash from Investing (Quarterly) | 14.10M |
| Cash from Financing (Quarterly) | -413.20M |
| Free Cash Flow Per Share (Quarterly) | 0.0577 |
| Free Cash Flow to Equity (Quarterly) | 34.80M |
| Free Cash Flow to Firm (Quarterly) | 35.00M |
| Free Cash Flow Yield | 1.19% |